文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

系统评价:嗜酸性食管炎中纤维狭窄定义的变异性

Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis.

作者信息

Beveridge Claire A, Farha Natalie, Hermanns Christina, Maruggi Chiara, Falloon Katherine, Thanawala Shivani, Harnegie Mary Pat, Brown J Mark, Ivanov Andrei I, Dellon Evan S, Falk Gary W, Ma Christopher, Gonsalves Nirmala, Lembo Anthony, Muir Amanda B, Gabbard Scott, Furuta Glenn T, Rieder Florian

机构信息

Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

出版信息

Aliment Pharmacol Ther. 2025 Aug;62(3):277-299. doi: 10.1111/apt.70187. Epub 2025 Jun 19.


DOI:10.1111/apt.70187
PMID:40536425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12239969/
Abstract

BACKGROUND: Fibrostenosis is a serious complication of eosinophilic oesophagitis, but there is a lack of consensus regarding its definition and assessment. This poses a barrier in clinical care and research. AIM: To perform a systematic review to examine existing definitions and diagnostic methods of detection regarding fibrostenosis in eosinophilic oesophagitis. METHODS: We searched MEDLINE, Cochrane Library, EMBASE, Scopus, and Web of Science and included studies of paediatric and adult eosinophilic oesophagitis patients with fibrostenosis based on endoscopy, imaging, histopathology, functional studies, and biomarkers. We excluded studies with <10 patients. We chose fibrostenosis as the umbrella term, encompassing all definitions. RESULTS: We identified 230 studies. The four categories of fibrostenosis definitions were: (1) structural findings (stricture, rings, and/or narrowings) (n=204, 88.7%), (2) histology (n=85, 37.0%), (3) functional (functional lumen imaging probe) (n=15, 6.5%), and (4) biomarkers (n=7, 3.0%). Multiple definitions were used in 78 studies. Methods used to detect structural fibrostenosis included Eosinophilic Oesophagitis Endoscopic Reference Score fibrostenotic components, luminal diameter (endoscopy or imaging), need for dilation, and endoscopist or radiologist global impression. Methods used to detect histologic fibrostenosis included Eosinophilic Oesophagitis Histologic Scoring System lamina propria fibrosis, pathologist global impression, and basal zone hyperplasia. Methods used to detect functional fibrostenosis included distensibility and compliance. CONCLUSIONS: Significant variability exists in definitions and diagnostic methods of detection regarding fibrostenosis in eosinophilic oesophagitis. Lack of agreement hampers progress in further investigating this complication. Development of consensus criteria is necessary to provide clarity for clinical care and research.

摘要

背景:纤维狭窄是嗜酸性粒细胞性食管炎的一种严重并发症,但关于其定义和评估缺乏共识。这在临床护理和研究中构成了障碍。 目的:进行一项系统评价,以研究嗜酸性粒细胞性食管炎中纤维狭窄的现有定义和检测诊断方法。 方法:我们检索了MEDLINE、Cochrane图书馆、EMBASE、Scopus和科学网,并纳入了基于内镜检查、影像学、组织病理学、功能研究和生物标志物的儿童和成人嗜酸性粒细胞性食管炎合并纤维狭窄患者的研究。我们排除了患者少于10例的研究。我们选择纤维狭窄作为总括性术语,涵盖所有定义。 结果:我们识别出230项研究。纤维狭窄的四类定义为:(1)结构表现(狭窄、环和/或狭窄处)(n = 204,88.7%),(2)组织学(n = 85,37.0%),(3)功能(功能腔成像探头)(n = 15,6.5%),以及(4)生物标志物(n = 7,3.0%)。78项研究使用了多种定义。用于检测结构性纤维狭窄的方法包括嗜酸性粒细胞性食管炎内镜参考评分的纤维狭窄成分、管腔直径(内镜检查或影像学)、扩张需求以及内镜医师或放射科医师的整体印象。用于检测组织学纤维狭窄的方法包括嗜酸性粒细胞性食管炎组织学评分系统的固有层纤维化、病理学家的整体印象以及基底区增生。用于检测功能性纤维狭窄的方法包括扩张性和顺应性。 结论:嗜酸性粒细胞性食管炎中纤维狭窄的定义和检测诊断方法存在显著差异。缺乏一致性阻碍了对这一并发症进一步研究的进展。制定共识标准对于为临床护理和研究提供清晰指导很有必要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f00/12239969/3eb094d78618/APT-62-277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f00/12239969/ced3d96ad757/APT-62-277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f00/12239969/3eb094d78618/APT-62-277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f00/12239969/ced3d96ad757/APT-62-277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f00/12239969/3eb094d78618/APT-62-277-g003.jpg

相似文献

[1]
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis.

Aliment Pharmacol Ther. 2025-8

[2]
Development and Validation of the PICK-UP-STRICS Score to Predict Fibrostenosis in Patients with EoE Prior to Endoscopy.

Dig Dis Sci. 2025-1

[3]
Anti-IL5 therapies for asthma.

Cochrane Database Syst Rev. 2017-9-21

[4]
Pharmacological treatment of children with gastro-oesophageal reflux.

Cochrane Database Syst Rev. 2014-11-24

[5]
The measurement and monitoring of surgical adverse events.

Health Technol Assess. 2001

[6]
Anti-IL-5 therapies for asthma.

Cochrane Database Syst Rev. 2022-7-12

[7]
Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis.

Aliment Pharmacol Ther. 2017-7

[8]
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.

Health Technol Assess. 2024-10

[9]
Review article: oesophageal dilation in adults with eosinophilic oesophagitis.

Aliment Pharmacol Ther. 2011-2-14

[10]
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Cochrane Database Syst Rev. 2015-6-23

本文引用的文献

[1]
Real world treatment patterns in patients with eosinophilic esophagitis in Japan.

Sci Rep. 2024-11-11

[2]
A retrospective real-world study on the safety and efficacy of budesonide orodispersible tablets for the induction therapy of eosinophilic oesophagitis.

Therap Adv Gastroenterol. 2024-10-16

[3]
Impact of cannabis use on presentation and treatment response in eosinophilic esophagitis.

Dis Esophagus. 2025-1-7

[4]
Health State Utility is Substantially Reduced With an Increasing Burden of Patient-Reported Symptoms in Eosinophilic Esophagitis.

Am J Gastroenterol. 2025-4-1

[5]
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome.

Dig Liver Dis. 2025-1

[6]
Effectiveness of treatment with budesonide orodispersible tablets in 76 patients with eosinophilic oesophagitis - real-life experience from the population-based DanEoE cohort.

Scand J Gastroenterol. 2024-10

[7]
Course of Esophageal Strictures in Eosinophilic Esophagitis Using Structured Esophagram Protocol.

Gastro Hep Adv. 2024-1-24

[8]
Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment response.

Allergy. 2024-12

[9]
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis.

J Allergy Clin Immunol Pract. 2024-9

[10]
Identification of gaps in the delivery of high-quality care of patients with eosinophilic esophagitis.

Dis Esophagus. 2025-1-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索